Tadalafil: What It Is, How It Works, and Why the Path to Treatment Matters

In the clinical world, relatively few compounds earn both a respected evidence base and genuine patient familiarity. Tadalafil is one of them. Introduced initially as a treatment for erectile dysfunction, it has since demonstrated utility across a broader range of conditions — a trajectory that reflects not pharmaceutical fashion, but a well-understood mechanism with consistent, evidence-grounded results across a diversity of patients.

For anyone who encounters the name through a prescription, a clinical conversation, or a personal search for information, the following article aims to provide a clear and honest account: what tadalafil is, how it works, what it can and cannot do, and why the route to obtaining it safely is inseparable from the treatment itself.

What Is Tadalafil?

Tadalafil belongs to a class of medicines known as phosphodiesterase type 5 (PDE5) inhibitors — compounds that work by modulating a specific enzyme involved in smooth muscle relaxation and blood flow regulation. It is marketed under several brand names, most widely recognised as Cialis, and may be prescribed either as a daily low-dose formulation or as a higher dose taken as required, depending on the clinical indication.

The compound was first approved for erectile dysfunction — defined as the consistent inability to achieve or maintain an erection sufficient for satisfactory sexual activity — but is now also indicated for benign prostatic hyperplasia (BPH), an enlargement of the prostate gland that impairs urinary flow, and pulmonary arterial hypertension (PAH), a serious condition characterised by elevated blood pressure in the pulmonary vasculature.

How Does Tadalafil Work?

To understand tadalafil’s mechanism, it helps to consider the role of cyclic guanosine monophosphate — abbreviated as cGMP — a signalling molecule that prompts smooth muscle cells to relax. When smooth muscle within blood vessel walls relaxes, the vessel widens, increasing blood flow to the surrounding tissue. Under normal physiological conditions, cGMP is broken down relatively rapidly by the PDE5 enzyme.

Tadalafil works by selectively inhibiting PDE5, allowing cGMP to accumulate and sustain its relaxing effect for a longer period. The clinical consequences differ by site of action: in erectile tissue, improved blood flow during sexual stimulation facilitates erection; in the prostate and bladder neck, reduced smooth muscle tension eases urinary symptoms; in the pulmonary vasculature, diminished vascular resistance lowers the workload on the right side of the heart.

One feature that distinguishes tadalafil from other PDE5 inhibitors is its notably long plasma half-life — approximately 17.5 hours — which translates to an effective duration of action of up to 36 hours following a single dose. This pharmacokinetic profile makes the daily low-dose formulation particularly practical for those who prefer a consistent therapeutic effect without planning doses around specific moments.

Clinical Indications

Erectile Dysfunction

Tadalafil is among the most extensively studied treatments for erectile dysfunction. Clinical trials have consistently demonstrated improvements in erectile function across a broad range of patients, including those with comorbidities such as type 2 diabetes, hypertension, and cardiovascular disease — populations that have historically proven more challenging to treat with PDE5 inhibitors. Response rates in these groups have been a particular area of clinical interest.

Benign Prostatic Hyperplasia

In men with BPH, tadalafil 5 mg taken once daily has been shown in randomised controlled trials to reduce lower urinary tract symptoms — including urinary frequency, urgency, a weak stream, and a sensation of incomplete bladder emptying. Notably, the same formulation addresses both erectile dysfunction and BPH simultaneously in men who experience both conditions concurrently, offering a clinically practical and well-tolerated approach to dual management.

Pulmonary Arterial Hypertension

At higher prescribed doses, tadalafil has demonstrated significant improvements in exercise capacity and a meaningful delay in clinical deterioration among patients with PAH. This indication is managed exclusively within specialist settings, with dosing that differs substantially from that used in other indications. It is included here for completeness, as it illustrates the range of evidence underpinning this compound.

Side Effects and Safety Considerations

Like all medicines, tadalafil carries a side effect profile that warrants careful consideration prior to use. The most commonly reported adverse effects include:

• Headache
• Facial flushing
• Dyspepsia — indigestion or upper abdominal discomfort
• Nasal congestion
• Back pain and myalgia (muscle ache), particularly associated with the daily formulation

These effects are generally mild to moderate in severity and tend to resolve without intervention. More serious, though uncommon, adverse effects include sudden changes in vision or hearing, and priapism — a prolonged erection lasting more than four hours that requires immediate medical attention.

Tadalafil must not be taken concurrently with nitrate medications — a class that includes glyceryl trinitrate and isosorbide mononitrate, commonly prescribed for angina. The combination can produce a sudden and potentially life-threatening fall in blood pressure. This interaction is absolute and without exception. Additional caution is warranted in individuals with severe cardiovascular disease, significant hepatic impairment, uncontrolled hypertension or hypotension, or hereditary degenerative retinal conditions such as retinitis pigmentosa.

A thorough medical assessment prior to commencing tadalafil is therefore not merely advisable — it is a prerequisite for safe and appropriate use.

Tadalafil in Thailand: Legal Status and Regulatory Framework

In Thailand, tadalafil is classified as a specially controlled drug under the regulatory authority of the Thai Food and Drug Administration (FDA Thailand). This classification has a clear and unambiguous consequence: tadalafil is available by prescription only. It cannot lawfully be purchased over the counter from a pharmacy, dispensed without a valid prescription issued by a licensed medical practitioner, or supplied through any channel that bypasses the formal prescribing process.

This regulatory position reflects the clinical reality that appropriate medical oversight is essential — not a bureaucratic inconvenience, but a meaningful safeguard. Given tadalafil’s potential interactions with other medicines, the importance of an accurate underlying diagnosis, and the need for dose calibration to individual circumstances, a qualified clinician is integral to the process of treatment, not incidental to it.

Individuals who obtain tadalafil through unregulated channels risk receiving counterfeit or substandard product, forgo the clinical evaluation that makes treatment safe and effective, and may expose themselves to genuine medical risk. In a market where counterfeit versions of PDE5 inhibitors are not uncommon, this concern is not theoretical.

At a Glance: Key Information

Aspect	Key Information
Drug class	PDE5 inhibitor (phosphodiesterase type 5 inhibitor)
Primary indications	Erectile dysfunction; benign prostatic hyperplasia; pulmonary arterial hypertension
Mechanism of action	Inhibits PDE5 enzyme → increased cGMP → smooth muscle relaxation → vasodilation
Duration of action	Up to 36 hours following a single dose
Typical dosing	5 mg daily (BPH / daily ED); 10–20 mg as required (ED); 40 mg daily (PAH)
Common side effects	Headache, facial flushing, dyspepsia, back pain, nasal congestion, myalgia
Key contraindication	Nitrate medications (absolute); severe cardiovascular disease; significant hepatic impairment
Legal status in Thailand	Prescription only — not available over the counter

The table above provides a concise reference summary and does not substitute for clinical assessment. Individual circumstances — comorbidities, concurrent medications, and personal health objectives — will always shape the most appropriate approach.

Frequently Asked Questions

Is tadalafil the same as Cialis?

Cialis is the original branded formulation of tadalafil; a number of generic versions are now available, all containing the same active compound at equivalent doses. The choice between branded and generic formulations is generally a matter of patient preference and clinical context, and is best discussed with a prescribing practitioner.

How long does tadalafil take to work, and how long does it last?

Tadalafil typically reaches peak plasma concentration within approximately two hours of ingestion and may remain clinically active for up to 36 hours following a single dose. It does not produce an erection in the absence of sexual stimulation; arousal remains necessary for the mechanism to take effect.

Can I take tadalafil if I have a heart condition?

Many individuals with stable cardiovascular disease take tadalafil safely under appropriate medical supervision. However, it is contraindicated in those using nitrate medications and in certain high-risk cardiac profiles. A thorough clinical assessment is essential before commencing treatment, and this question should always be raised candidly with the prescribing clinician.

What is the difference between the daily and on-demand formulations?

The daily formulation — typically 2.5 mg or 5 mg — maintains a low, steady level of the medication in the body, removing the need to plan around anticipated activity. The on-demand formulation, generally 10 mg or 20 mg, is taken as required, ordinarily 30 to 60 minutes beforehand. The more appropriate approach depends on the individual’s lifestyle, frequency of use, and clinical profile.

Can I obtain tadalafil from a chemist in Thailand without a prescription?

No. Tadalafil is a prescription-only medicine in Thailand, classified as a specially controlled drug by FDA Thailand. It cannot legally be dispensed from any pharmacy without a valid prescription from a licensed medical practitioner. Any source offering tadalafil without a prescription operates outside the regulated supply chain.

Are there foods or drinks I should avoid whilst taking tadalafil?

Large quantities of grapefruit or grapefruit juice may affect the metabolism of tadalafil and are best avoided. Alcohol does not directly interact with tadalafil but may independently impair erectile function and can compound the blood-pressure-lowering effect — moderation is therefore advisable.

Is tadalafil prescribed only for men?

Tadalafil is prescribed predominantly in male patients for erectile dysfunction and BPH, but is used in both men and women for pulmonary arterial hypertension. Research into applications in women for sexual health indications continues, though this remains an area of emerging rather than established clinical evidence.

A Final Word

Tadalafil is a well-studied, clinically versatile medicine with a robust evidence base and a clearly defined safety profile. With appropriate guidance from a qualified practitioner, it offers a reliable and well-tolerated option for the conditions it is indicated to treat. A consultation with an experienced clinician ensures a personalised and considered approach — one calibrated to the individual’s medical history, concurrent medications, and health objectives, rather than to a generic protocol.

For those based in Thailand, this consultation is also the legally required first step — and, in the view of any clinician working in this field, the right one.

References

1. Porst H, Giuliano F, Glina S, Ralph D, Casabé AR, Elion-Mboussa A, et al. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5 mg and 10 mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial. European Urology. 2006;50(2):351–359.

2. Egerdie RB, Auerbach S, Roehrborn CG, Costa P, Garza MS, Lakin MM, et al. Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study. Journal of Sexual Medicine. 2012;9(1):271–281.

3. Galiè N, Brundage BH, Ghofrani HA, Oudiz RJ, Simonneau G, Safdar Z, et al. Tadalafil therapy for pulmonary arterial hypertension. Circulation. 2009;119(22):2894–2903.

4. Roehrborn CG, Chapple C, Oelke M, Cox D, Esler A, Viktrup L. Effects of tadalafil once daily on maximum urinary flow rate in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Journal of Urology. 2014;191(6):1712–1716.

5. McMahon CN, Smith CJ, Shabsigh R. Treating erectile dysfunction when PDE5 inhibitors fail. British Medical Journal. 2006;332(7541):589–592.

6. Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F, et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. European Urology. 2010;57(5):804–814.

7. Kloner RA, Emmick JT, Bedding A, Mitchel J, Whitaker JS, Jacobsen G, et al. Pharmacodynamic interactions between tadalafil and nitrates compared with sildenafil. Journal of the American College of Cardiology. 2003;42(10):1855–1860.

8. Forgue ST, Patterson BE, Bedding AW, Payne CD, Phillips DL, Wrishko RE, et al. Tadalafil pharmacokinetics in healthy subjects. British Journal of Clinical Pharmacology. 2006;61(3):280–288.

This article is for patient education only and does not constitute medical advice. Consult a qualified medical practitioner before commencing any new treatment.